Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH)

被引：4
|
作者：
Boucly, Athenais [1 ]
Savale, Laurent [1 ]
Weatherald, Jason [1 ]
Montani, David [1 ]
Jevnikar, Mitja [1 ]
Jais, Xavier [1 ]
Simonneau, Gerald [1 ]
Humbert, Marc [1 ]
Sitbon, Olivier [1 ]
机构：
[1] Univ Paris Sud, Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.OA271
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA271
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of Initial Triple Combination Therapy on Long-Term Survival in Pulmonary Arterial Hypertension (PAH)
    Boucly, A.
    Savale, L.
    Weatherald, J. C.
    Montani, D.
    Cottin, V.
    Dauphin, C.
    Picard, F.
    Fard, D.
    Mignard, X.
    Jutant, E.
    Jevnikar, M.
    Jais, X.
    Simonneau, G.
    Humbert, M.
    Sitbon, O.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [2] Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension
    Boucly, Athenais
    Savale, Laurent
    Jais, Xavier
    Bauer, Fabrice
    Bergot, Emmanuel
    Bertoletti, Laurent
    Beurnier, Antoine
    Bourdin, Arnaud
    Bouvaist, Helene
    Bulifon, Sophie
    Chabanne, Celine
    Chaouat, Ari
    Cottin, Vincent
    Dauphin, Claire
    Degano, Bruno
    De Groote, Pascal
    Favrolt, Nicolas
    Feng, Yuanchao
    Horeau-Langlard, Delphine
    Jevnikar, Mitja
    Jutant, Etienne-Marie
    Liang, Zhiying
    Magro, Pascal
    Mauran, Pierre
    Moceri, Pamela
    Mornex, Jean-Francois
    Palat, Sylvain
    Parent, Florence
    Picard, Francois
    Pichon, Jeremie
    Poubeau, Patrice
    Prevot, Gregoire
    Renard, Sebastien
    Reynaud-Gaubert, Martine
    Riou, Marianne
    Roblot, Pascal
    Sanchez, Olivier
    Seferian, Andrei
    Tromeur, Cecile
    Weatherald, Jason
    Simonneau, Gerald
    Montani, David
    Humbert, Marc
    Sitbon, Olivier
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (07) : 842 - 854
  • [3] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [4] Impact of initial therapeutic strategy on long-term outcomes in pulmonary arterial hypertension: An analysis of the PHSANZ registry
    Kearney, K.
    Lavender, M.
    Cordina, R.
    Collins, N.
    Corrigan, C.
    Dwyer, N.
    Feenstra, J.
    Keating, D.
    McWilliams, T.
    Williams, T.
    Whitford, H.
    Whyte, K.
    Weintraub, R.
    Wrobel, J.
    Keogh, A.
    Kotlyar, E.
    Lau, E.
    [J]. RESPIROLOGY, 2022, 27 : 50 - 50
  • [5] Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry
    Kearney, K.
    Lavender, M.
    Cordina, R.
    Collins, N.
    Corrigan, C.
    Dwyer, N.
    Feenstra, J.
    Keating, D.
    McWilliams, T.
    Williams, T.
    Whitford, H.
    Wrobel, J.
    Keogh, A.
    Kotlyar, E.
    Lau., E.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S27 - S28
  • [6] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    [J]. PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [8] Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival
    Heresi, Gustavo A.
    Love, Thomas E.
    Tonelli, Adriano R.
    Highland, Kristin B.
    Dweik, Raed A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) : 1090 - 1093
  • [9] Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
    Preston, Ioana R.
    Roberts, Kari E.
    Miller, Dave P.
    Sen, Ginny P.
    Selej, Mona
    Benton, Wade W.
    Hill, Nicholas S.
    Farber, Harrison W.
    [J]. CIRCULATION, 2015, 132 (25) : 2403 - 2411
  • [10] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
    Kremers, Hilal Maradit
    Slusser, Joshua P.
    Scott, Christopher G.
    Primatesta, Paola
    McGoon, Michael D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
12345